Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05464537 · ClinicalTrials.gov registry record · NA
Efficacy Rate of Unipolar Polarity Switch for Lesion Assessment in Pulmonary Vein Isolation
A NA study, sponsored by Kansas City Heart Rhythm Research Foundation.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT05464537: Clinical Trial NA study, sponsored by Kansas City Heart Rhythm Research Foundation.
NCT05464537 is a NA study that was terminated before completion, run by Kansas City Heart Rhythm Research Foundation. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05464537, a NA study, was terminated before completion, sponsored by Kansas City Heart Rhythm Research Foundation.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The technique of intraprocedural electrogram morphology as a measure of lesion effectiveness in an attempt to achieve durable PVI, clearly led to shortened procedural time, radiation exposure, and superiority in outcomes, with the implementation of a reproducible, readily available intraprocedural tool that can be applied universally.
Primary Outcome
Observe the efficacy rate of loss of unipolar negative component in isolation of the Pulmonary Veins. Loss of unipolar negative component will be assessed during the Radiofrequency ablation procedure. The durability of Pulmonary vein isolation will be assessed at 12 month follow up, if there is recurrence of Atrial fibrillation.
Interventions
- OTHER Unipolar Polarity Switch Left
- OTHER Unipolar Polarity Switch Right
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2023-08-28 |
| Est. Completion | 2024-11-27 |
| Phase | NA |
Why NCT05464537 stopped before completion
NCT05464537 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Unipolar Polarity Switch Left is the first listed.
NCT05464537 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05464537 about?
NCT05464537 is a clinical study titled "Efficacy Rate of Unipolar Polarity Switch for Lesion Assessment in Pulmonary Vein Isolation". The technique of intraprocedural electrogram morphology as a measure of lesion effectiveness in an attempt to achieve durable PVI, clearly led to shortened procedural time, radiation exposure, and superiority in outcomes, with the implementation of a reproducible, readily available intraprocedural t...
What is the current status of trial NCT05464537?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2023-08-28. Estimated completion is 2024-11-27.
What interventions are being tested in trial NCT05464537?
The interventions under investigation include: Unipolar Polarity Switch Left (OTHER), Unipolar Polarity Switch Right (OTHER).
Who is sponsoring clinical trial NCT05464537?
This trial is sponsored by Kansas City Heart Rhythm Research Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05464537's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI